Compounded semaglutide, tirzepatide and liraglutide could be harder to come by starting this summer, if the U.S. Food and Drug Administration (FDA) goes through with its plan to remove the three ...

Health-care marketplace Sesame announced a new clinical weight loss program that will help eligible consumers access compounded versions of Novo Nordisk’s blockbuster obesity drug Wegovy for $249 per ...

In recent years, an increasing number of health care providers and patients have turned to compounded drugs for the treatment of hormone-related health concerns. These products are often marketed as ...